Jorde, Lynn B.; Carey, John C.; Bamshad, Michael J. Medical Genetics(ingilis) (5). Elsevier Health Sciences. 2015. səh. 120. ISBN978-0-323-18837-1. 2020-12-15 tarixində arxivləşdirilib. İstifadə tarixi: 2021-06-30.
Cortés M, F; Alliende R, MA; Barrios R, A; Curotto L, B; Santa María V, L; Barraza O, X; Troncoso A, L; Mellado S, C; Pardo V, R. "[Clinical, genetic and molecular features in 45 patients with Prader-Willi syndrome]". Revista Médica de Chile. 133 (1). January 2005: 33–41. doi:10.4067/s0034-98872005000100005. PMID15768148.
Buiting, K; Saitoh, S; Gross, S; Dittrich, B; Schwartz, S; Nicholls, RD; Horsthemke, B. "Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15". Nature Genetics. 9 (4). April 1995: 395–400. doi:10.1038/ng0495-395. PMID7795645.
Whittington J, Holland A, Webb T, Butler J, Clarke D, Boer H. "Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome". J Intellect Disabil Res. 48 (Pt 2). February 2004: 172–87. doi:10.1111/j.1365-2788.2004.00556.x. PMID14723659.
Runte M, Varon R, Horn D, Horsthemke B, Buiting K. "Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome". Hum Genet. 116 (3). 2005: 228–30. doi:10.1007/s00439-004-1219-2. PMID15565282.
Ding F, Prints Y, Dhar MS, Johnson DK, Garnacho-Montero C, Nicholls RD, Francke U. "Lack of Pwcr1/MBII-85 snoRNA is critical for neonatal lethality in Prader-Willi syndrome mouse models". Mamm Genome. 16 (6). 2005: 424–31. doi:10.1007/s00335-005-2460-2. PMID16075369.
Carrel AL, Myers SE, Whitman BY, Allen DB. "Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study". J. Clin. Endocrinol. Metab. 87 (4). April 2002: 1581–5. doi:10.1210/jc.87.4.1581. PMID11932286.
Höybye C, Hilding A, Jacobsson H, Thorén M. "Growth hormone treatment improves body composition in adults with Prader-Willi syndrome". Clin. Endocrinol. 58 (5). May 2003: 653–61. doi:10.1046/j.1365-2265.2003.01769.x. PMID12699450.
Cortés M, F; Alliende R, MA; Barrios R, A; Curotto L, B; Santa María V, L; Barraza O, X; Troncoso A, L; Mellado S, C; Pardo V, R. "[Clinical, genetic and molecular features in 45 patients with Prader-Willi syndrome]". Revista Médica de Chile. 133 (1). January 2005: 33–41. doi:10.4067/s0034-98872005000100005. PMID15768148.
Curfs LM, Fryns JP. "Prader-Willi syndrome: a review with special attention to the cognitive and behavioral profile". Birth Defects Orig. Artic. Ser. 28 (1). 1992: 99–104. PMID1340242.
Buiting, K; Saitoh, S; Gross, S; Dittrich, B; Schwartz, S; Nicholls, RD; Horsthemke, B. "Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15". Nature Genetics. 9 (4). April 1995: 395–400. doi:10.1038/ng0495-395. PMID7795645.
Whittington J, Holland A, Webb T, Butler J, Clarke D, Boer H. "Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome". J Intellect Disabil Res. 48 (Pt 2). February 2004: 172–87. doi:10.1111/j.1365-2788.2004.00556.x. PMID14723659.
"Prader-Willi Syndrome - MeSH - NCBI." National Center for Biotechnology Information. U.S. National Library of Medicine, n.d. Web. November 1, 2016. <"Prader-Willi Syndrome - MeSH - NCBI". November 3, 2016 tarixində arxivləşdirilib. İstifadə tarixi: November 1, 2016.>.
Runte M, Varon R, Horn D, Horsthemke B, Buiting K. "Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome". Hum Genet. 116 (3). 2005: 228–30. doi:10.1007/s00439-004-1219-2. PMID15565282.
Ding F, Prints Y, Dhar MS, Johnson DK, Garnacho-Montero C, Nicholls RD, Francke U. "Lack of Pwcr1/MBII-85 snoRNA is critical for neonatal lethality in Prader-Willi syndrome mouse models". Mamm Genome. 16 (6). 2005: 424–31. doi:10.1007/s00335-005-2460-2. PMID16075369.
Carrel AL, Myers SE, Whitman BY, Allen DB. "Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study". J. Clin. Endocrinol. Metab. 87 (4). April 2002: 1581–5. doi:10.1210/jc.87.4.1581. PMID11932286.
Höybye C, Hilding A, Jacobsson H, Thorén M. "Growth hormone treatment improves body composition in adults with Prader-Willi syndrome". Clin. Endocrinol. 58 (5). May 2003: 653–61. doi:10.1046/j.1365-2265.2003.01769.x. PMID12699450.
Jorde, Lynn B.; Carey, John C.; Bamshad, Michael J. Medical Genetics(ingilis) (5). Elsevier Health Sciences. 2015. səh. 120. ISBN978-0-323-18837-1. 2020-12-15 tarixində arxivləşdirilib. İstifadə tarixi: 2021-06-30.
"Prader-Willi Syndrome - MeSH - NCBI." National Center for Biotechnology Information. U.S. National Library of Medicine, n.d. Web. November 1, 2016. <"Prader-Willi Syndrome - MeSH - NCBI". November 3, 2016 tarixində arxivləşdirilib. İstifadə tarixi: November 1, 2016.>.